BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8069519)

  • 1. Solid state chemical instability of an asparaginyl residue in a model hexapeptide.
    Oliyai C; Patel JP; Carr L; Borchardt RT
    J Pharm Sci Technol; 1994; 48(3):167-23. PubMed ID: 8069519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical pathways of peptide degradation. VII. Solid state chemical instability of an aspartyl residue in a model hexapeptide.
    Oliyai C; Patel JP; Carr L; Borchardt RT
    Pharm Res; 1994 Jun; 11(6):901-8. PubMed ID: 7937533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide.
    Patel K; Borchardt RT
    Pharm Res; 1990 Jul; 7(7):703-11. PubMed ID: 2395797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a histidine residue on the C-terminal side of an asparaginyl residue on the rate of deamidation using model pentapeptides.
    Goolcharran C; Stauffer LL; Cleland JL; Borchardt RT
    J Pharm Sci; 2000 Jun; 89(6):818-25. PubMed ID: 10824141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acidic N + 1 residues on asparagine deamidation rates in solution and in the solid state.
    Li B; Gorman EM; Moore KD; Williams T; Schowen RL; Topp EM; Borchardt RT
    J Pharm Sci; 2005 Mar; 94(3):666-75. PubMed ID: 15668945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deamidation via cyclic imide in asparaginyl peptides.
    Capasso S; Mazzarella L; Sica F; Zagari A
    Pept Res; 1989; 2(2):195-200. PubMed ID: 2520758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone.
    Pikal MJ; Dellerman K; Roy ML
    Dev Biol Stand; 1992; 74():21-37; discussion 37-8. PubMed ID: 1592171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical stability of peptides in polymers. 2. Discriminating between solvent and plasticizing effects of water on peptide deamidation in poly(vinylpyrrolidone).
    Lai MC; Hageman MJ; Schowen RL; Borchardt RT; Laird BB; Topp EM
    J Pharm Sci; 1999 Oct; 88(10):1081-9. PubMed ID: 10514359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sucrose and mannitol on asparagine deamidation rates of model peptides in solution and in the solid state.
    Li B; O'Meara MH; Lubach JW; Schowen RL; Topp EM; Munson EJ; Borchardt RT
    J Pharm Sci; 2005 Aug; 94(8):1723-35. PubMed ID: 15986465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racemization of an asparagine residue during peptide deamidation.
    Li B; Borchardt RT; Topp EM; VanderVelde D; Schowen RL
    J Am Chem Soc; 2003 Sep; 125(38):11486-7. PubMed ID: 13129337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides.
    Patel K; Borchardt RT
    Pharm Res; 1990 Aug; 7(8):787-93. PubMed ID: 2235875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH- and thermal-dependent conformational transition of PGAIPG, a repeated hexapeptide sequence from tropoelastin.
    Lin SY; Hsieh TF; Wei YS
    Peptides; 2005 Apr; 26(4):543-9. PubMed ID: 15752567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.
    Oliyai C; Borchardt RT
    Pharm Res; 1993 Jan; 10(1):95-102. PubMed ID: 8430066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of viscosity on the deamidation rate of a model Asn-hexapeptide.
    Li R; Hageman MJ; Topp EM
    J Pept Res; 2002 May; 59(5):211-20. PubMed ID: 11966978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism-based kinetic analysis of succinimide-mediated deamidation, racemization, and covalent adduct formation in a model peptide in amorphous lyophiles.
    Dehart MP; Anderson BD
    J Pharm Sci; 2012 Sep; 101(9):3096-109. PubMed ID: 22271437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality by design in formulation and process development for a freeze-dried, small molecule parenteral product: a case study.
    Mockus LN; Paul TW; Pease NA; Harper NJ; Basu PK; Oslos EA; Sacha GA; Kuu WY; Hardwick LM; Karty JJ; Pikal MJ; Hee E; Khan MA; Nail SL
    Pharm Dev Technol; 2011; 16(6):549-76. PubMed ID: 21932931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of solid-state acidity on the decomposition of sucrose in amorphous systems. I.
    Alkhamis KA
    Int J Pharm; 2008 Oct; 362(1-2):74-80. PubMed ID: 18647642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of peptide conformation in the rate and mechanism of deamidation of asparaginyl residues.
    Lura R; Schirch V
    Biochemistry; 1988 Oct; 27(20):7671-7. PubMed ID: 3207697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon.
    Joshi AB; Kirsch LE
    Int J Pharm; 2004 Apr; 273(1-2):213-9. PubMed ID: 15010145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues.
    Nabuchi Y; Fujiwara E; Kuboniwa H; Asoh Y; Ushio H
    Pharm Res; 1997 Dec; 14(12):1685-90. PubMed ID: 9453054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.